Uncategorized
Fixed dose combination proves superior in reducing diurnal IOP
CORONADO, Calif. — A fixed-dose combination of IOP-lowering medications reduced diurnal IOP more effectively than its constituent components dosed individually, according to a scientific poster presented here.Jason Bacharach, MD, and colleagues reported that PG324 ophthalmic solution (Aerie Pharmaceuticals) proved superior to both latanoprost and AR-13324 (Aerie) in reducing IOP over 1 month.